{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T07:03:15Z","timestamp":1784358195692,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12404-7","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:29:13Z","timestamp":1784356153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic spectrum and treatment implications of maturity-onset diabetes of the young in the eastern Black Sea region of T\u00fcrkiye: a combined adult and pediatric cohort of 296 patients with identification of rare and novel variants"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5068-0380","authenticated-orcid":false,"given":"\u00c7a\u011fr\u0131","family":"Do\u011fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8680-0313","authenticated-orcid":false,"given":"Burak","family":"Anda\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7817-2871","authenticated-orcid":false,"given":"Mehtap","family":"Navdar Ba\u015faran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0645-2070","authenticated-orcid":false,"given":"Yasemin","family":"Em\u00fcr G\u00fcnay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1563-2292","authenticated-orcid":false,"given":"Mustafa Tar\u0131k","family":"Alay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8549-5564","authenticated-orcid":false,"given":"Aysel","family":"Kalayc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"key":"12404_CR1","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00125-017-4226-2","volume":"60","author":"AT Hattersley","year":"2017","unstructured":"Hattersley AT, Patel KA (2017) Precision diabetes: learning from monogenic diabetes. Diabetologia 60:769\u2013777. https:\/\/doi.org\/10.1007\/s00125-017-4226-2","journal-title":"Diabetologia"},{"key":"12404_CR2","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/pedi.13426","volume":"23","author":"SAW Greeley","year":"2022","unstructured":"Greeley SAW, Polak M, Nj\u00f8lstad PR, Barbetti F, Williams R, Castano L et al (2022) ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes 23:1188\u20131211. https:\/\/doi.org\/10.1111\/pedi.13426","journal-title":"Pediatr Diabetes"},{"key":"12404_CR3","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1007\/s00125-010-1799-4","volume":"53","author":"BM Shields","year":"2010","unstructured":"Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, Ellard S (2010) Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53:2504\u20132508. https:\/\/doi.org\/10.1007\/s00125-010-1799-4","journal-title":"Diabetologia"},{"key":"12404_CR4","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.2337\/dc11-0035","volume":"34","author":"SS Fajans","year":"2011","unstructured":"Fajans SS, Bell GI (2011) MODY: history, genetics, pathophysiology, and clinical decision making. Diabetes Care 34:1878\u20131884. https:\/\/doi.org\/10.2337\/dc11-0035","journal-title":"Diabetes Care"},{"key":"12404_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1464-5491.2009.02690.x","volume":"26","author":"M Shepherd","year":"2009","unstructured":"Shepherd M, Shields B, Ellard S, Rubio-Cabezas O, Hattersley AT (2009) A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients. Diabet Med 26:437\u2013441. https:\/\/doi.org\/10.1111\/j.1464-5491.2009.02690.x","journal-title":"Diabet Med"},{"key":"12404_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1515\/jpem-2014-0384","volume":"28","author":"A Anik","year":"2015","unstructured":"Anik A, Catli G, Abaci A, Bober E (2015) Maturity-onset diabetes of the young (MODY): an update. J Pediatr Endocrinol Metab 28:251\u2013263. https:\/\/doi.org\/10.1515\/jpem-2014-0384","journal-title":"J Pediatr Endocrinol Metab"},{"key":"12404_CR7","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S0140-6736(03)14571-0","volume":"362","author":"ER Pearson","year":"2003","unstructured":"Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT (2003) Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 362:1275\u20131281. https:\/\/doi.org\/10.1016\/S0140-6736(03)14571-0","journal-title":"Lancet"},{"key":"12404_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00125-011-2319-x","volume":"55","author":"P Bowman","year":"2012","unstructured":"Bowman P, Flanagan SE, Edghill EL, Damhuis A, Shepherd MH, Paisey R et al (2012) Heterozygous ABCC8 mutations are a cause of MODY. Diabetologia 55:123\u2013127. https:\/\/doi.org\/10.1007\/s00125-011-2319-x","journal-title":"Diabetologia"},{"key":"12404_CR9","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.2337\/dc14-2769","volume":"38","author":"AJ Chakera","year":"2015","unstructured":"Chakera AJ, Steele AM, Gloyn AL, Shepherd MH, Shields B, Ellard S et al (2015) Recognition and management of individuals with hyperglycemia because of a heterozygous glucokinase mutation. Diabetes Care 38:1383\u20131392. https:\/\/doi.org\/10.2337\/dc14-2769","journal-title":"Diabetes Care"},{"key":"12404_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11892-019-1131-8","volume":"19","author":"Y Horikawa","year":"2019","unstructured":"Horikawa Y, Enya M (2019) Genetic dissection and clinical features of MODY6 (NEUROD1-MODY). Curr Diab Rep 19:12. https:\/\/doi.org\/10.1007\/s11892-019-1131-8","journal-title":"Curr Diab Rep"},{"key":"12404_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ajhg.2015.05.011","volume":"97","author":"S Prudente","year":"2015","unstructured":"Prudente S, Jungtrakoon P, Marucci A, Ludovico O, Buranasupkajorn P, Mazza T et al (2015) Loss-of-function mutations in APPL1 in familial diabetes mellitus. Am J Hum Genet 97:177\u2013185. https:\/\/doi.org\/10.1016\/j.ajhg.2015.05.011","journal-title":"Am J Hum Genet"},{"key":"12404_CR12","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1007\/s00125-013-2962-5","volume":"56","author":"S Ellard","year":"2013","unstructured":"Ellard S, Lango Allen H, De Franco E, Flanagan SE, Hysenaj G, Colclough K et al (2013) Improved genetic testing for monogenic diabetes using targeted next-generation sequencing. Diabetologia 56:1958\u20131963. https:\/\/doi.org\/10.1007\/s00125-013-2962-5","journal-title":"Diabetologia"},{"key":"12404_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"12404_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1056\/NEJMoa061759","volume":"355","author":"ER Pearson","year":"2006","unstructured":"Pearson ER, Flechtner I, Nj\u00f8lstad PR, Malecki MT, Flanagan SE, Larkin B et al (2006) Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 355:467\u2013477. https:\/\/doi.org\/10.1056\/NEJMoa061759","journal-title":"N Engl J Med"},{"key":"12404_CR15","doi-asserted-by":"publisher","first-page":"e3459","DOI":"10.1002\/dmrr.3459","volume":"37","author":"M Timmers","year":"2021","unstructured":"Timmers M, Dirinck E, Lauwers P, Wuyts W, De Block C (2021) ABCC8 variants in MODY12: review of the literature and report of a case with severe complications. Diabetes Metab Res Rev 37:e3459. https:\/\/doi.org\/10.1002\/dmrr.3459","journal-title":"Diabetes Metab Res Rev"},{"key":"12404_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/ng1708","volume":"38","author":"H Raeder","year":"2006","unstructured":"Raeder H, Johansson S, Holm PI, Haldorsen IS, Mas E, Sbarra V et al (2006) Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet 38:54\u201362. https:\/\/doi.org\/10.1038\/ng1708","journal-title":"Nat Genet"},{"key":"12404_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s42255-021-00516-2","volume":"4","author":"S Kahraman","year":"2022","unstructured":"Kahraman S, Dirice E, Basile G, Diegisser D, Alam J, Johansson BB et al (2022) Abnormal exocrine\u2013endocrine cell cross-talk promotes \u03b2-cell dysfunction and loss in MODY8. Nat Metab 4:76\u201389. https:\/\/doi.org\/10.1038\/s42255-021-00516-2","journal-title":"Nat Metab"},{"key":"12404_CR18","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1007\/s00125-018-4728-6","volume":"61","author":"MH Shepherd","year":"2018","unstructured":"Shepherd MH, Shields BM, Hudson M, Pearson ER, Hyde C, Ellard S et al (2018) A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin. Diabetologia 61:2520\u20132527. https:\/\/doi.org\/10.1007\/s00125-018-4728-6","journal-title":"Diabetologia"},{"key":"12404_CR19","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.ajhg.2022.09.014","volume":"109","author":"UL Mirshahi","year":"2022","unstructured":"Mirshahi UL, Colclough K, Wright CF, Wood AR, Beaumont RN, Tyrrell J et al (2022) Reduced penetrance of MODY-associated HNF1A\/HNF4A variants but not GCK variants in clinically unselected cohorts. Am J Hum Genet 109:2018\u20132028. https:\/\/doi.org\/10.1016\/j.ajhg.2022.09.014","journal-title":"Am J Hum Genet"},{"key":"12404_CR20","doi-asserted-by":"publisher","first-page":"4035026","DOI":"10.1155\/pedi\/4035026","volume":"2025","author":"A Sanri","year":"2025","unstructured":"Sanri A, Kontbay Cetin T, Acikgoz EG, Mutlu MB, Sezer O (2025) Revealing monogenic diabetes: clinical and genetic features of pediatric MODY cases in T\u00fcrkiye: single center experience. Pediatr Diabetes 2025:4035026. https:\/\/doi.org\/10.1155\/pedi\/4035026","journal-title":"Pediatr Diabetes"},{"key":"12404_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00592-023-02197-7","volume":"61","author":"SMC De Sousa","year":"2024","unstructured":"De Sousa SMC, Wu KHC, Colclough K, Rawlings L, Dubowsky A, Monnik M et al (2024) Identification of monogenic diabetes in an Australian cohort using the Exeter maturity-onset diabetes of the young (MODY) probability calculator and next-generation sequencing gene panel testing. Acta Diabetol 61:223\u2013231. https:\/\/doi.org\/10.1007\/s00592-023-02197-7","journal-title":"Acta Diabetol"},{"key":"12404_CR22","doi-asserted-by":"publisher","first-page":"13853","DOI":"10.1038\/s41598-026-43760-w","volume":"16","author":"M Hasan","year":"2026","unstructured":"Hasan M, Sultana N, Shil KK et al (2026) Diverse and rare candidate MODY gene variants were identified in one-fifth of a Bangladeshi cohort with nonobese, nonautoimmune youth-onset diabetes. Sci Rep 16:13853. https:\/\/doi.org\/10.1038\/s41598-026-43760-w","journal-title":"Sci Rep"},{"key":"12404_CR23","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s13410-021-01032-5","volume":"42","author":"S Yal\u00e7\u0131ntepe","year":"2022","unstructured":"Yal\u00e7\u0131ntepe S, \u00d6zg\u00fc\u00e7 \u00c7\u00f6mlek F, G\u00fcrkan H, Demir S, Atl\u0131 E\u0130, Atl\u0131 E et al (2022) Maturity-onset diabetes of the young (MODY)-related genetic variants in a Turkish patient cohort with early-onset diabetes: a cross-sectional study. Int J Diabetes Dev Ctries 42:617\u2013624. https:\/\/doi.org\/10.1007\/s13410-021-01032-5","journal-title":"Int J Diabetes Dev Ctries"},{"key":"12404_CR24","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1089\/omi.2021.0081","volume":"25","author":"D Kanca Demirci","year":"2021","unstructured":"Kanca Demirci D, Darendeliler F, Poyrazoglu S, Kardelen Al AD, Gul N, Tutuncu Y et al (2021) Monogenic childhood diabetes: dissecting clinical heterogeneity by next-generation sequencing in maturity-onset diabetes of the young. OMICS 25:431\u2013449. https:\/\/doi.org\/10.1089\/omi.2021.0081","journal-title":"OMICS"},{"key":"12404_CR25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/cen.13076","volume":"85","author":"B Haliloglu","year":"2016","unstructured":"Haliloglu B, Hysenaj G, Atay Z, Guran T, Abali S, Turan S, Bereket A, Ellard S (2016) GCK gene mutations are a common cause of childhood-onset MODY (maturity-onset diabetes of the young) in T\u00fcrkiye. Clin Endocrinol (Oxf) 85:393\u2013399. https:\/\/doi.org\/10.1111\/cen.13076","journal-title":"Clin Endocrinol (Oxf)"},{"key":"12404_CR26","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1399-0004.2011.01655.x","volume":"81","author":"M Borowiec","year":"2012","unstructured":"Borowiec M, Antosik K, Fendler W, Deja G, Jarosz-Chobot P, Mysliwiec M et al (2012) Novel glucokinase mutations in patients with monogenic diabetes \u2014 clinical outline of GCK-MD and potential for founder effect in Slavic population. Clin Genet 81:278\u2013283. https:\/\/doi.org\/10.1111\/j.1399-0004.2011.01655.x","journal-title":"Clin Genet"},{"key":"12404_CR27","doi-asserted-by":"publisher","unstructured":"Sharp LN, Mirshahi UL, Colclough K, Hall TS, Haley JS, Cannon SJ et al (2025) MODY is prevalent in later-onset diabetes, has potential for targeted therapy but is challenging to identify [preprint]. https:\/\/doi.org\/10.1101\/2025.06.17.25329143. medRxiv","DOI":"10.1101\/2025.06.17.25329143"},{"key":"12404_CR28","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.2337\/db21-0844","volume":"71","author":"TW Laver","year":"2022","unstructured":"Laver TW, Wakeling MN, Knox O, Colclough K, Wright CF, Ellard S, Hattersley AT, Weedon MN, Patel KA (2022) Evaluation of evidence for pathogenicity demonstrates that BLK, KLF11, and PAX4 should not be included in diagnostic testing for MODY. Diabetes 71:1128\u20131136. https:\/\/doi.org\/10.2337\/db21-0844","journal-title":"Diabetes"},{"key":"12404_CR29","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.2337\/db25-0442","volume":"74","author":"A Sriram","year":"2025","unstructured":"Sriram A, Wakeling MN, Hattersley AT, Weedon MN, Colclough K, Laver TW, Patel KA (2025) Rare variants in NEUROD1 and PDX1 are low-penetrance causes of MODY, whereas those in APPL1 and WFS1 are not associated with MODY. Diabetes 74:2123\u20132131. https:\/\/doi.org\/10.2337\/db25-0442","journal-title":"Diabetes"},{"key":"12404_CR30","doi-asserted-by":"publisher","first-page":"e142244","DOI":"10.1172\/JCI142244","volume":"131","author":"S Misra","year":"2021","unstructured":"Misra S, Owen KR (2021) Monogenic diabetes: a gateway to precision medicine in diabetes. J Clin Invest 131:e142244. https:\/\/doi.org\/10.1172\/JCI142244","journal-title":"J Clin Invest"},{"key":"12404_CR31","doi-asserted-by":"publisher","first-page":"e1455","DOI":"10.1210\/clinem\/dgab864","volume":"107","author":"K El Jellas","year":"2022","unstructured":"El Jellas K, Du\u0161\u00e1tkov\u00e1 P, Haldorsen IS, Molnes J, Tjora E, Johansson BB, Fjeld K, Johansson S, Pr\u016fhov\u00e1 \u0160, Groop L, L\u00f6hr JM, Nj\u00f8lstad PR, Molven A (2022) Two new mutations in the CEL gene causing diabetes and hereditary pancreatitis: how to correctly identify MODY8 cases. J Clin Endocrinol Metab 107:e1455\u2013e1466. https:\/\/doi.org\/10.1210\/clinem\/dgab864","journal-title":"J Clin Endocrinol Metab"},{"key":"12404_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12020-023-03447-y","volume":"83","author":"S Sun","year":"2024","unstructured":"Sun S, Gong S, Li M, Wang X, Wang F, Cai X et al (2024) Clinical and genetic characteristics of CEL-MODY (MODY8): a literature review and screening in Chinese individuals diagnosed with early-onset type 2 diabetes. Endocrine 83:99\u2013109. https:\/\/doi.org\/10.1007\/s12020-023-03447-y","journal-title":"Endocrine"},{"key":"12404_CR33","doi-asserted-by":"publisher","first-page":"101280","DOI":"10.1016\/j.molmet.2021.101280","volume":"52","author":"J St\u00f8y","year":"2021","unstructured":"St\u00f8y J, De Franco E, Ye H, Park SY, Bell GI, Hattersley AT (2021) In celebration of a century with insulin \u2014 update of insulin gene mutations in diabetes. Mol Metab 52:101280. https:\/\/doi.org\/10.1016\/j.molmet.2021.101280","journal-title":"Mol Metab"},{"key":"12404_CR34","doi-asserted-by":"publisher","first-page":"1590935","DOI":"10.3389\/fmed.2025.1590935","volume":"12","author":"C Gulisano","year":"2025","unstructured":"Gulisano C, Aloi C, Salina A, Marazzi C, Spacco G, Cappato S, Bocciardi R, Iafusco D, Tantari G, d\u2019Annunzio G, Minuto N, Maghnie M, Bassi M, Faravelli F (2025) Case report: beyond type 1 diabetes: a case of delayed MODY1 diagnosis and successful transition to sulfonylurea therapy. Front Med (Lausanne) 12:1590935. https:\/\/doi.org\/10.3389\/fmed.2025.1590935","journal-title":"Front Med (Lausanne)"},{"key":"12404_CR35","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1007\/s00125-023-06003-5","volume":"66","author":"AE Hughes","year":"2023","unstructured":"Hughes AE, Houghton JAL, Bunce B, Chakera AJ, Spyer G, Shepherd MH, Flanagan SE, Hattersley AT (2023) Bringing precision medicine to the management of pregnancy in women with glucokinase-MODY: a study of diagnostic accuracy and feasibility of non-invasive prenatal testing. Diabetologia 66:2222\u20132231. https:\/\/doi.org\/10.1007\/s00125-023-06003-5","journal-title":"Diabetologia"},{"key":"12404_CR36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.2337\/dc13-0410","volume":"37","author":"RN Naylor","year":"2014","unstructured":"Naylor RN, John PM, Winn AN, Carmody D, Greeley SAW, Philipson LH, Bell GI, Huang ES (2014) Cost-effectiveness of MODY genetic testing: translating genomic advances into practical health applications. Diabetes Care 37:202\u2013209. https:\/\/doi.org\/10.2337\/dc13-0410","journal-title":"Diabetes Care"},{"key":"12404_CR37","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00125-026-06685-7","volume":"69","author":"TW Laver","year":"2026","unstructured":"Laver TW, Sriram A, Wakeling MN, \u015eiklar Z, Kobaisi F, Kalyon O, Hattersley AT, Weedon MN, Flanagan SE, De Franco E, Colclough K, Patel KA (2026) Systematic analysis of loss-of-function variants across MODY genes demonstrates gene-specific effects and expands the spectrum of INS variants causing MODY. Diabetologia 69:1569\u20131580. https:\/\/doi.org\/10.1007\/s00125-026-06685-7","journal-title":"Diabetologia"},{"key":"12404_CR38","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1093\/ejendo\/lvaf172","volume":"193","author":"TW Laver","year":"2025","unstructured":"Laver TW, Patel KA (2025) Maturity onset diabetes of the young and beyond: the changing face of single-gene diabetes. Eur J Endocrinol 193:R25\u2013R29. https:\/\/doi.org\/10.1093\/ejendo\/lvaf172","journal-title":"Eur J Endocrinol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12404-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12404-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12404-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:29:14Z","timestamp":1784356154000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12404-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12404"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12404-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]},"assertion":[{"value":"16 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Clinical Research Ethics Committee of Ordu University (decision 2025\/274, dated 18 July 2025).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for genetic testing and for the use of de-identified clinical data in research had been obtained from all participants or, for participants under 18 years of age, from their parents or legal guardians at the time of testing. The ethics committee waived the need for additional consent for this retrospective analysis given the use of fully de-identified data.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable; no individually identifying data are included.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1201"}}